SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS

Background. Neoadjuvant chemotherapy (NACT) is a standard of care for locally advanced breast cancer patients. One of the main advantages of NACT is the reduction of the tumor size and regression of lymph node metastasis.The aim of the study was to analyze the outcomes of breast-conserving surgery a...

Full description

Saved in:
Bibliographic Details
Main Authors: A. R. Bosieva, M. V. Ermoshchenkova, A. D. Zikiryakhodzhayev, N. N. Volchenko
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2021-05-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/1764
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849700008678391808
author A. R. Bosieva
M. V. Ermoshchenkova
A. D. Zikiryakhodzhayev
N. N. Volchenko
author_facet A. R. Bosieva
M. V. Ermoshchenkova
A. D. Zikiryakhodzhayev
N. N. Volchenko
author_sort A. R. Bosieva
collection DOAJ
description Background. Neoadjuvant chemotherapy (NACT) is a standard of care for locally advanced breast cancer patients. One of the main advantages of NACT is the reduction of the tumor size and regression of lymph node metastasis.The aim of the study was to analyze the outcomes of breast-conserving surgery after NACT compared to adjuvant chemotherapy, including the examination of the width of resection margins and the frequency of re-operations, the volume of tissue removed and cosmetic outcomes.Material and Methods. We analyzed 1219 publications available from pubMed, Medline, Cochrane Library, 1057 of them did not meet the inclusion criteria, 162 publications were selected to cover all the following inclusion criteria: surgical margin status, frequency of re-operations, volume of tissue removed and cosmetic outcomes. Finally, 22 studies met fully specified criteria.Results. Studies included in this review demonstrated a different frequency of positive resection margins (2–39.8 %), reoperations (0–45.4 %), the volume of tissue removed (43.2–268 cm3), and the weight of the resected breast tissue (26.4–233 grams) after NACT.  Conclusion. The data obtained showed a decrease in the frequency of positive resection margins and re-operations in patients who received NACT compared to patients who did not receive NACT (5–39.8 % versus 13.1–46 % and 0–45.4 % versus 0–76.5 %, respectively), as well as a decrease in the amount of the removed breast tissue without the negative effect on the frequency of resection margins, thus allowing minimization of the extent of surgery and improvement of cosmetic outcomes.
format Article
id doaj-art-e830e501addc496f9aba3f64cc9ade86
institution DOAJ
issn 1814-4861
2312-3168
language Russian
publishDate 2021-05-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj-art-e830e501addc496f9aba3f64cc9ade862025-08-20T03:18:24ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682021-05-0120211812610.21294/1814-4861-2021-20-2-118-126852SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTSA. R. Bosieva0M. V. Ermoshchenkova1A. D. Zikiryakhodzhayev2N. N. Volchenko3P. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian FederationFederal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University); The City Clinical Oncological Hospital № 1 of the Moscow Health departmentP. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)P. Hertsen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian FederationBackground. Neoadjuvant chemotherapy (NACT) is a standard of care for locally advanced breast cancer patients. One of the main advantages of NACT is the reduction of the tumor size and regression of lymph node metastasis.The aim of the study was to analyze the outcomes of breast-conserving surgery after NACT compared to adjuvant chemotherapy, including the examination of the width of resection margins and the frequency of re-operations, the volume of tissue removed and cosmetic outcomes.Material and Methods. We analyzed 1219 publications available from pubMed, Medline, Cochrane Library, 1057 of them did not meet the inclusion criteria, 162 publications were selected to cover all the following inclusion criteria: surgical margin status, frequency of re-operations, volume of tissue removed and cosmetic outcomes. Finally, 22 studies met fully specified criteria.Results. Studies included in this review demonstrated a different frequency of positive resection margins (2–39.8 %), reoperations (0–45.4 %), the volume of tissue removed (43.2–268 cm3), and the weight of the resected breast tissue (26.4–233 grams) after NACT.  Conclusion. The data obtained showed a decrease in the frequency of positive resection margins and re-operations in patients who received NACT compared to patients who did not receive NACT (5–39.8 % versus 13.1–46 % and 0–45.4 % versus 0–76.5 %, respectively), as well as a decrease in the amount of the removed breast tissue without the negative effect on the frequency of resection margins, thus allowing minimization of the extent of surgery and improvement of cosmetic outcomes.https://www.siboncoj.ru/jour/article/view/1764breast cancerneoadjuvant chemotherapybreast-conserving surgerymargin statusvolume of tissue removedcosmetic outcomes
spellingShingle A. R. Bosieva
M. V. Ermoshchenkova
A. D. Zikiryakhodzhayev
N. N. Volchenko
SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
Сибирский онкологический журнал
breast cancer
neoadjuvant chemotherapy
breast-conserving surgery
margin status
volume of tissue removed
cosmetic outcomes
title SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
title_full SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
title_fullStr SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
title_full_unstemmed SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
title_short SYSTEMATIC REVIEW AND METAANALYSIS OF THE RESULTS OF BREAST-CONSERVING SURGERY AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
title_sort systematic review and metaanalysis of the results of breast conserving surgery after neoadjuvant chemotherapy in breast cancer patients
topic breast cancer
neoadjuvant chemotherapy
breast-conserving surgery
margin status
volume of tissue removed
cosmetic outcomes
url https://www.siboncoj.ru/jour/article/view/1764
work_keys_str_mv AT arbosieva systematicreviewandmetaanalysisoftheresultsofbreastconservingsurgeryafterneoadjuvantchemotherapyinbreastcancerpatients
AT mvermoshchenkova systematicreviewandmetaanalysisoftheresultsofbreastconservingsurgeryafterneoadjuvantchemotherapyinbreastcancerpatients
AT adzikiryakhodzhayev systematicreviewandmetaanalysisoftheresultsofbreastconservingsurgeryafterneoadjuvantchemotherapyinbreastcancerpatients
AT nnvolchenko systematicreviewandmetaanalysisoftheresultsofbreastconservingsurgeryafterneoadjuvantchemotherapyinbreastcancerpatients